Semiquantitation of cooperativity in binding of vancomycin-group antibiotics to vancomycin-susceptible and -resistant organisms

被引:40
作者
Beauregard, DA
Maguire, AJ
Williams, DH
Reynolds, PE
机构
[1] UNIV CAMBRIDGE,CHEM LAB,CAMBRIDGE CTR MOL RECOGNIT,CAMBRIDGE CB2 1EW,ENGLAND
[2] DEPT BIOCHEM,CAMBRIDGE CB2 1QW,ENGLAND
关键词
D O I
10.1128/AAC.41.11.2418
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The association of vancomycin group antibiotics with the growing bacterial cell wall was investigated by using the cell wall precursor analog di-N-acetyl-Lys-D-Ala-D-Ala in competition binding experiments. The affinities of the antibiotics for the -D-Ala-D-Ala-containing cell wall precursors of Bacillus subtilis ATCC 6633 (a model for vancomycin-susceptible gram-positive bacteria) and for the -D-Ala-D-Lac-containing cell wall precursors of Leuconostoc mesenteroides (a model for vancomycin-resistant strains of Enterococcus faecium and Enterococcus faecalis) were determined by a whole-cell assay. The binding of strongly dimerizing antibiotics such as eremomycin to the bacterial surface was thus shown to be enhanced by up to 2 orders of magnitude (relative to the binding in free solution) by the chelate effect, whereas weakly dimerizing antibiotics like vancomycin and antibiotics carrying lipid tails (teicoplanin) benefited less (ca. 1 order of magnitude). The affinity measured in this way correlates well with the MIC of the antibiotic, and a consequence of this is that future design of semisynthetic vancomycin-group antibiotics should attempt to incorporate chelate effect-enhancing structural features.
引用
收藏
页码:2418 / 2423
页数:6
相关论文
共 28 条
[1]   Inhibition of peptidoglycan biosynthesis in vancomycin-susceptible and -resistant bacteria by a semisynthetic glycopeptide antibiotic [J].
Allen, NE ;
Hobbes, JN ;
Nicas, TI .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (10) :2356-2362
[2]   Molecular interactions of a semisynthetic glycopeptide antibiotic with D-alanyl-D-alanine and D-alanyl-D-lactate residues [J].
Allen, NE ;
LeTourneau, DL ;
Hobbs, JN .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (01) :66-71
[3]   Quantitative analysis of the metabolism of soluble cytoplasmic peptidoglycan precursors of glycopeptide-resistant enterococci [J].
Arthur, M ;
Depardieu, F ;
Reynolds, P ;
Courvalin, P .
MOLECULAR MICROBIOLOGY, 1996, 21 (01) :33-44
[4]   DIMERIZATION AND MEMBRANE ANCHORS IN EXTRACELLULAR TARGETING OF VANCOMYCIN GROUP ANTIBIOTICS [J].
BEAUREGARD, DA ;
WILLIAMS, DH ;
GWYNN, MN ;
KNOWLES, DJC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (03) :781-785
[5]   MODIFICATION OF PEPTIDOGLYCAN PRECURSORS IS A COMMON FEATURE OF THE LOW-LEVEL VANCOMYCIN-RESISTANT VANB-TYPE ENTEROCOCCUS D366 AND OF THE NATURALLY GLYCOPEPTIDE-RESISTANT SPECIES LACTOBACILLUS-CASEI, PEDIOCOCCUS-PENTOSACEUS, LEUCONOSTOC-MESENTEROIDES, AND ENTEROCOCCUS-GALLINARUM [J].
BILLOTKLEIN, D ;
GUTMANN, L ;
SABLE, S ;
GUITTET, E ;
VANHEIJENOORT, J .
JOURNAL OF BACTERIOLOGY, 1994, 176 (08) :2398-2405
[6]   MOLECULAR-BASIS FOR VANCOMYCIN RESISTANCE IN ENTEROCOCCUS-FAECIUM BM4147 - BIOSYNTHESIS OF A DEPSIPEPTIDE PEPTIDOGLYCAN PRECURSOR BY VANCOMYCIN RESISTANCE PROTEINS VANH AND VANA [J].
BUGG, TDH ;
WRIGHT, GD ;
DUTKAMALEN, S ;
ARTHUR, M ;
COURVALIN, P ;
WALSH, CT .
BIOCHEMISTRY, 1991, 30 (43) :10408-10415
[7]  
CAVELLERI B, 1992, ENCY CHEM TECHNOLOGY, V2, P995
[8]  
COOPER RDG, 1995, 35 INT C ANT AG CHEM, P155
[9]  
DANCER RJ, 1996, J CHEM SOC CHEM COMM, V12, P1445
[10]   MM-45289, A POTENT GLYCOPEPTIDE ANTIBIOTIC WHICH INTERACTS WEAKLY WITH DIACETYL-L-LYSYL-D-ALANYL-D-ALANINE [J].
GOOD, VM ;
GWYNN, MN ;
KNOWLES, DJC .
JOURNAL OF ANTIBIOTICS, 1990, 43 (05) :550-555